FdaApplication
NDA 020747
Identifiers
- fda_app_no: NDA020747
Properties
| Property | Value |
|---|---|
| applicant_name | CEPHALON LLC |
| application_type | NDA |
| approval_date | 1998-11-04 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACTIQ | FENTANYL CITRATE | EQ 0.8MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
| ACTIQ | FENTANYL CITRATE | EQ 1.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
| ACTIQ | FENTANYL CITRATE | EQ 0.2MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
| ACTIQ | FENTANYL CITRATE | EQ 1.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
| ACTIQ | FENTANYL CITRATE | EQ 0.4MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
| ACTIQ | FENTANYL CITRATE | EQ 0.6MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TROCHE/LOZENGE;TRANSMUCOSAL |
6 products